
    
      120 post MI patients on CCU will be studied during the first week of admission. Patients will
      be categorised using the following criteria: Infarct size and site; PMH; Co-morbidities;
      Drugs; Regular caffeine ingestion.

      Patients will be randomised to receive either caffeinated or de-caffeinated coffee or tea
      during admission. HRV will be assessed by non-invasive Holter-monitoring on the fifth day.
      Salivary caffeine concentration will be assessed concurrently to assess compliance.
    
  